Product Categories
| Country: | China |
|---|---|
| Tel: | 13720134139 086-15871494362 |
| Mobile: | +8613720134139 |
| E-mail: | orders@jknbiochem.com |
| QQ: | 3655618288 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ezabenlimab | 2249882-54-8 | Details |
| Demupitamab | 2249926-74-5 | Details |
| Finotonlimab | 2350298-85-8 | Details |
| Emerfetamab | 2250261-27-7 | Details |
| Cirevetmab | 2473240-98-9 | Details |
| Varokibart | 2643349-04-4 | Details |
| LEM-14 | C25H26N4O4S | 1814881-70-3 | Details |
| DT-2216 | C77H96ClF3N10O10S4 | 2365172-42-3 | Details |
| Izuralimab | 2329669-80-7 | Details |
| Gresonitamab | 2413817-97-5 | Details |
| CYCLOSPORINE | C62H111N11O12 | 79217-60-0 | Details |
| Arecoline hydrobromide | C8H14BrNO2 | 300-08-3 | Details |
| 3-DeazaneplanocinAhydrochloride | C12H15ClN4O3 | 120964-45-6 | Details |
| 2-formyl-3-hydroxybenzoic acid | C8H6O4 | 1243461-12-2 | Details |
| ARV-771 | C49H60ClN9O7S2 | 1949837-12-0 | Details |
| Epcoritamab | 2134641-34-0 | Details |
| Pavurutamab | 2250292-39-6 | Details |
| Depemokimab | 2243274-14-6 | Details |
| Nofazinlimab | 2377845-98-0 | Details |
| Tuvonralimab | 2417649-44-4 | Details |
| Dalnicastobart | 2642171-59-1 | Details |
| Forimtamig | 2649379-96-2 | Details |
| WEHI-539 | C31H29N5O3S2 | 1431866-33-9 | Details |
| MI-503 | C28H27F3N8S | 1857417-13-0 | Details |
| GSK621 | C26H20ClN3O5 | 1346607-05-3 | Details |
| Serclutamab | 2140172-41-2 | Details |
| Cotosudil | C16 H21 N3 O2 S | 1258833-31-6 | Details |
| YB-0158 | C32H35N7NaO7P | 1144043-83-3 | Details |
| BMS-P5 | C27H33ClN6O2 | 1549811-36-0 | Details |
| Pimurutamab | 2251771-76-1 | Details |
| Geptanolimab | 2348469-43-0 | Details |
| Recaticimab | 2361290-85-7 | Details |
| Vixtimotamab | 2243775-32-6 | Details |
| Frexalimab | 2515463-86-0 | Details |
| (S)-2-Fluoropropanoicacid | C3H5FO2 | 57965-29-4 | Details |
| BAY 1161909 | C29H26FN5O4S | 1443763-60-7 | Details |
| (R)-METHYL 3-(5-BROMOPYRIDIN-2-YL)-2-(BOC-AMINO)PROPANOATE | C14H19BrN2O4 | 1391465-94-3 | Details |
| (S)-3-PHENYLCYCLOHEXANONE | C12H14O | 57344-86-2 | Details |
| Peresolimab | 2411580-63-5 | Details |
| Etevritamab | 2329692-74-0 | Details |
| (4R)-4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | C24H40O3 | 1534-35-6 | Details |
| Research Grade Casirivimab | 2415933-42-3 | Details |
| Anti-CD40LG | 252662-47-8 | Details |
| GW-6471 | C35H36F3N3O4 | 880635-03-0 | Details |
| 3-BroMoiMidazo[5,1-b]thiazole-7-carboxylic acid | C6H3BrN2O2S | 1352898-75-9 | Details |
| Rogaratinib（BAY1163877） | C23H26N6O3S | 1443530-05-9 | Details |
| (R)-GNE-140 | C25H23ClN2O3S2 | 2003234-63-5 | Details |
| IRAK4-IN-7 | C21H19N7O3 | 1801343-74-7 | Details |
| Itraconazole | C35H38Cl2N8O4 | 84625-61-6 | Details |
| Demcizumab | 1243262-17-0 | Details |
| Spartalizumab | 1935694-88-4 | Details |
| Datopotamab | 2267989-53-5 | Details |
| Tarlatamab | 2307488-83-9 | Details |
| Sotigalimab | 2305607-45-6 | Details |
| Ubamatamab | 2305629-50-7 | Details |
| Sotrovimab | 2423014-07-5 | Details |
| Latikafusp | 2552814-07-8 | Details |
| Glofitamab | 2229047-91-8 | Details |
| GMB-475 | C43H46F3N7O7S | 2490599-18-1 | Details |
| methyl (2S)-3-(5-bromopyridin-2-yl)-2-[(2-methylpropan-2- yl)oxycarbonylamino]-propanoate | C14H19BrN2O4 | 656801-27-3 | Details |
| Clervonafusp Alfa | 2250440-41-4 | Details |
| Penpulimab | 2350298-92-7 | Details |
| Nivatrotamab | 2278244-14-5 | Details |
| Lomvastomig | 2648840-52-0 | Details |
| Research Grade Imdevimab | 2415933-40-1 | Details |
| (R)-3-PHENYLCYCLOHEXANONE | C12H14O | 34993-51-6 | Details |
| THAL-SNS-032 | C40H52N8O10S2 | 2139287-33-3 | Details |
| Diridavumab | 1393659-46-5 | Details |
| Ensitrelvir | C30H33N5O5S | 1471484-62-4 | Details |
| Lorigerlimab | 2416595-46-3 | Details |
| Pulocimab | 2428381-49-9 | Details |
| Lipustobart | 2639481-06-2 | Details |
| Emirodatamab | 2449199-61-3 | Details |
| Izalontamab | 2559704-24-2 | Details |
| PF-562271 | C21H20F3N7O3S | 717907-75-0 | Details |
| CPI-0610 | C20H16ClN3O2 | 1380087-89-7 | Details |
| VHL-298 | C27H33N5O4S | 2097381-85-4 | Details |
| LLY-283 | C17H18N4O4 | 2040291-27-6 | Details |
| ACBI-1 | C49H58FN9O7S | 2375564-55-7 | Details |
| Ensitrelvir fumarate | C22H17ClF3N9O2.C4H4O4 | 2757470-18-9 | Details |
| Vulinacimab | 2250342-36-8 | Details |
| Voxalatamab | 2411871-58-2 | Details |
| Iparomlimab | 2417649-33-1 | Details |
| Imvotamab | 2573121-53-4 | Details |
| Delpacibart | 2653183-68-5 | Details |
| Muromonab-Cd3 | 140608-64-6 | Details |
| beta-Glucuronidase inhibitor 1 | C23H27N3O3S | 484006-66-8 | Details |
| ASTX660 | C30H42FN5O3 | 1799328-86-1 | Details |
| Dectrekumab | 1528523-94-5 | Details |
| Pacanalotamab | 2251756-52-0 | Details |
| Pimivalimab | 2293951-22-9 | Details |
| Daxdilimab | 2245966-28-1 | Details |
| Obrindatamab | 2069959-72-2 | Details |
| Dargistotug | 2649362-29-6 | Details |
| Research Grade Tebentafusp | 1874157-95-5 | Details |
| AP20187 | C82H107N5O20 | 195514-80-8 | Details |
| NVP-2 | C27H37ClN6O2 | 1263373-43-8 | Details |
| Dilpacimab | 1791420-09-1 | Details |
| Serplulimab | 2231029-82-4 | Details |
| VB-124 | C23H23ClN2O4 | 2230186-18-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 | ||||